Sage Journals: Discover world-class research

Free access

Review article

First published 1999-12

Non-Nucleoside Reverse Transcriptase Inhibitors: The NNRTI Boom

Ole S Pedersen, Erik B Pedersen

Antiviral Chemistry and Chemotherapy

Open access

Case report

First published 2025-7

Factor XIa Inhibitor Reversal in Intracranial Hemorrhage: A Case Report

Arshed Al-Obeidi, Draia Garavito, Sierra Smalley [...]

The Neurohospitalist

Free access

Research article

First published 2017-10

Dynamic Compound-Dependent Acoustic Transfer to Investigate Inhibitor Reversibility

Jennifer Nothstein, Elisabeth MacColl, Paul Zuck [...]

Journal of Laboratory Automation

Open access

Research article

First published 2019

Reversal of Factor Xa Inhibitors by Andexanet Alfa May Increase Thrombogenesis Compared to Pretreatment Values

Fakiha Siddiqui, Alfonso Tafur, Lorenzo Storino Ramacciotti [...]

Clinical and Applied Thrombosis/Hemostasis

Open access

Research article

First published 2022-4

Efficacy of second-line dolutegravir plus 2 nucleoside reverse transcriptase inhibitors by baseline nucleoside reverse transcriptase inhibitor resistance and nucleoside reverse transcriptase inhibitor use in the DAWNING study

Dannae Brown, Richard Kaplan, Marcelo Losso [...]

Antiviral Therapy

Open access

Research article

First published 2021

Investigation of the Optimal Dose aPCC in Reversing the Effect of Factor Xa Inhibitors—An In Vitro Study

Nina Haagenrud Schultz, Jawed Fareed, Pål Andre Holme

Clinical and Applied Thrombosis/Hemostasis

Retricted access

Research article

First published 2009-10

Apricitabine: A Nucleoside Reverse Transcriptase Inhibitor for HIV Infection

Monica M Gaffney, Paul P Belliveau, Linda M Spooner

Annals of Pharmacotherapy

Retricted access

Research article

First published 2004-6

Emtricitabine: A Once-Daily Nucleoside Reverse Transcriptase Inhibitor

Krysten A Modrzejewski, Ronald A Herman

Annals of Pharmacotherapy

Free access

Research article

First published 1996-10

A Diarylsulphone Non-Nucleoside Reverse Transcriptase Inhibitor with a Unique Sensitivity Profile to Drug-Resistant Virus Isolates

R.W. Buckheit, V. Fliakas-Boltz, J.D. Russell [...]

Antiviral Chemistry and Chemotherapy

Free access

Research article

First published 2021-1

Effects of Reverse Transcriptase Inhibitors on Proliferation,Apoptosis,and Migration in Breast Carcinoma Cells

Zülal Atlı Şekeroğlu, Vedat Şekeroğlu, Nihan Küçük

International Journal of Toxicology

Search results